Rheumatology Advance Access originally published online on April 25, 2006
Rheumatology 2006 45(7):912-913; doi:10.1093/rheumatology/kel104
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The Author [2006]. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org
LETTER TO THE EDITOR |
Pneumococcal and influenza vaccination in patients with rheumatic conditions and receiving DMARD therapy
Rheumatology Department, Wrightington Hospital, Hall Lane, Appley Bridge, WN6 9EP, Lancashire, UK
Correspondence to: W. A. Fahy. E-mail: billy-fahy@doctors.org.uk
| The first 10% of the full text of this article appears below. |
SIR, It was interesting to read your editorial Vaccinate your immunocompromised patients! [1] and we would like to outline an audit performed at Wrightington Hospital, UK, which highlights this problem. Streptococcus pneumoniae, the most common cause of adult community-acquired pneumonia, has an annual incidence rate of